Iglesias, Estibaliz External Entity

Publications

Sort by

Selected publications

  • Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.  Arthritis and Rheumatology. 2017 In Process GET IT

Other